Therapy News and Research

RSS

One-day treatment with the anticancer drug carboplatin is as effective as radiotherapy for testicular cancer

One-day treatment with the anticancer drug carboplatin is as effective and less toxic than three weeks radiation therapy for a type of testicular cancer, according to a report published in this week’s issue of The Lancet.

21 Jul 2005

Role of IL-24 in regulating the immune system

Researchers at Introgen Therapeutics and their collaborators at The University of Texas M. D. Anderson Cancer Center have published new findings on the role of IL-24 in regulating the immune system in the current online issue of the Journal of Leukocyte Biology.

21 Jul 2005

ev3 announces FDA approval of treatment for brain vascular disorder

ev3 today announced that its majority-owned subsidiary Micro Therapeutics has received pre-market application (PMA) approval from the U.S. Food and Drug Administration (FDA) to commercialize its Onyx Liquid Embolic System (Onyx) for the treatment of arterio-venous malformations (AVMs), a vascular disorder in the brain.

21 Jul 2005

Crucial molecular link between a hepatitis B virus (HBV) and hepatocellular carcinoma (HCC)

Researchers at The University of Texas M. D. Anderson Cancer Center have uncovered a crucial molecular link between a viral infection and development of a common and fatal form of liver cancer. In the process, they have identified a possible way to treat this disease as well as a number of other cancers.

21 Jul 2005

Brain computer map could prevent strokes

A grant from the Neurological Foundation of New Zealand will allow researchers at the University of Canterbury New Zealand, to fine-tune a computer model of cerebral bloodflow that could become a tool in predicting, treating and preventing strokes.

21 Jul 2005

Imiquimod and fluorouracil emerge as effective weapons for treating superficial basal cell carcinomas

Basal cell carcinoma, a type of skin cancer, affects millions of people worldwide. While traditional treatment has been surgery and radiation, topical treatments in combination with surgery are showing more promise for patients with basal cell carcinoma.

21 Jul 2005

Innovative laser and light treatments to tackle acne, rosacea, sun damage and signs of aging

Millions of Americans suffer from skin conditions that affect their appearance and can cause emotional and social distress. Thanks to technological advances, many of these conditions are treatable with laser and light therapies which offer a faster way to improve appearance with less recovery time and a higher degree of safety.

21 Jul 2005

FDA approval for VNS Therapy will help people with epilepsy

The U.S. Food and Drug Administration's recent approval of Vagus Nerve Stimulation Therapy for treatment of chronic depression provides a novel single-treatment option for two major symptoms suffered by people with epilepsy.

21 Jul 2005

Evaluating how hospitals deliver medical care standardizes practices and improves care

In recent years, American hospitals have made significant improvements on standardized, evidence-based measures of clinical performance for several medical conditions, including heart attacks, heart failure, and pneumonia.

20 Jul 2005

Alendronate combined with calcium and vitamin D almost completely prevented further bone loss in the first 4 months afte liver transplant

A new study found that the drug used to treat osteoporosis, when used in combination with calcium and vitamin D, can prevent the additional bone loss that commonly occurs after liver transplants. The treatment also helped stabilize bone loss in patients who already had osteoporosis, and helped improve their bone mineral density (BMD).

20 Jul 2005

Metformin should be in the first line of defense against type 2 diabetes

A new review of studies confirms that the drug metformin should be in the first line of defense against type 2 diabetes. Using metformin alone can improve control of blood glucose, while also reducing risk factors for heart disease such as excess body weight, cholesterol levels and hypertension, the review found.

20 Jul 2005

Antibiotics should not be prescribed to patients with the common cold

Antibiotics should not be prescribed to patients with the common cold because there is scant evidence they stop other infections, and the benefits do not outweigh the risks, according to a new systematic review of current evidence.

19 Jul 2005

Study warns against global use of old asthma medicines for kids' coughs

An asthma medicine widely used around the world to stop children's coughs has no provable benefit for that purpose and may cause harm, a new review of existing studies reports.

19 Jul 2005

$New protective drugs called bisphosphonates reduce pain and fractures in metastatic breast cancer$

New protective drugs called bisphosphonates reduce pain and fractures in metastatic breast cancer

When breast cancer spreads to bones, relatively new protective drugs called bisphosphonates can reduce skeletal damage, says a new systematic review of previous studies. While the new treatment approach does not improve survival rates, it can minimize disabling fractures, spinal cord compression and pain.

19 Jul 2005

Combination of ribavirin and interferon is more effective in treating hepatitis C than using interferon alone

The researchers reviewed 72 randomized trials and 9,991 patients who had chronic hepatitis C for more than six months and were previously untreated, who had relapsed after treatment or who had not responded to other treatment.

19 Jul 2005

Study provides evidence that hormone treatments can be beneficial to limiting cardiovascular ailments

UC Irvine School of Medicine researchers have identified how estrogen helps prevents a cardiac ailment often seen in women who have heart attacks. This research provides further evidence that hormone replacement therapy after menopause can help prevent certain forms of cardiovascular disease in women.

19 Jul 2005

No single PSA level ensures safety from prostate cancer risk

Ian M. Thompson Jr., M.D., professor and chair of urology at the U T Health Science Center, is looking for a better test - or set of tests - to diagnose prostate cancer and to distinguish between cancers that will kill men if left untreated and those that will not threaten health and do not need treatment.

19 Jul 2005

Important find will help design appropriate screening and therapy for women carrying fetuses impaired in their growth

In her research, Dr. Andree Gruslin encountered many pregnant women who could not carry their fetuses to term because the placenta, and in turn the fetus, were too small. In once case, she followed a woman who had had eight consecutive miscarriages due to this condition. Thanks to this latest discovery, she now understands why.

19 Jul 2005

Removing warts without scarring

If burning and freezing warts hasn't worked, ask your dermatologist about getting a shot.

19 Jul 2005

1 in 166 children under age 10 are affected by autism

New statistics surrounding autism make it the number one growing developmental disability in the country. The Centers for Disease Control and Prevention estimates as many as one in 166 children under age 10 are affected by the disorder. Nearly two million people in the U.S. are living with autism.

19 Jul 2005

Therapy News and Research

One-day treatment with the anticancer drug carboplatin is as effective as radiotherapy for testicular cancer

Role of IL-24 in regulating the immune system

ev3 announces FDA approval of treatment for brain vascular disorder

Crucial molecular link between a hepatitis B virus (HBV) and hepatocellular carcinoma (HCC)

Brain computer map could prevent strokes

Imiquimod and fluorouracil emerge as effective weapons for treating superficial basal cell carcinomas

Innovative laser and light treatments to tackle acne, rosacea, sun damage and signs of aging

FDA approval for VNS Therapy will help people with epilepsy

Evaluating how hospitals deliver medical care standardizes practices and improves care

Alendronate combined with calcium and vitamin D almost completely prevented further bone loss in the first 4 months afte liver transplant

Metformin should be in the first line of defense against type 2 diabetes

Antibiotics should not be prescribed to patients with the common cold

Study warns against global use of old asthma medicines for kids' coughs

New protective drugs called bisphosphonates reduce pain and fractures in metastatic breast cancer

Combination of ribavirin and interferon is more effective in treating hepatitis C than using interferon alone

Study provides evidence that hormone treatments can be beneficial to limiting cardiovascular ailments

No single PSA level ensures safety from prostate cancer risk

Important find will help design appropriate screening and therapy for women carrying fetuses impaired in their growth

Removing warts without scarring

1 in 166 children under age 10 are affected by autism

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News